Phase 1 study of irinotecan (CPT-11) in patients with abnormal liver or renal function or with prior pelvic radiation therapy

Venook, A., Klein, C., Kastrissios, H., Leichman, C., Hollis, D., Hohl, R., Villalona, M. and Ratain, M. J. (2001). Phase 1 study of irinotecan (CPT-11) in patients with abnormal liver or renal function or with prior pelvic radiation therapy. In: News from the 37th annual meeting of the American Society of Clinical Oncologists. 37th Annual Meeting of American Society of Clinical Oncologists (ASCO), San Francisco, CA, USA, (293-293). 12-15 May, 2001.


Author Venook, A.
Klein, C.
Kastrissios, H.
Leichman, C.
Hollis, D.
Hohl, R.
Villalona, M.
Ratain, M. J.
Title of paper Phase 1 study of irinotecan (CPT-11) in patients with abnormal liver or renal function or with prior pelvic radiation therapy
Conference name 37th Annual Meeting of American Society of Clinical Oncologists (ASCO)
Conference location San Francisco, CA, USA
Conference dates 12-15 May, 2001
Proceedings title News from the 37th annual meeting of the American Society of Clinical Oncologists
Place of Publication USA
Publisher American Society of Clinical Oncology
Publication Year 2001
Sub-type Other
Open Access Status
Volume 2001
Issue 20
Start page 293
End page 293
Total pages 1
Language eng
Subjects EX
320503 Clinical Pharmacology and Therapeutics
730108 Cancer and related disorders
Q-Index Code EX

Document type: Conference Paper
Collection: School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: Google Scholar Search Google Scholar
Created: Fri, 24 Aug 2007, 00:18:18 EST